Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J F Snijders

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 23, 2015
Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trialsF Verdoodt, M Jentschke, P Hillemanns, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 14, 2008
[Flat penile lesions in the sexual transmission of human papillomavirus]M C G Bleeker, P J F Snijders, F J Voorhorst, et al.
Preventive Medicine|December 31, 2018
HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programmeN J Polman, P J F Snijders, G G Kenter, et al.
British Journal of Cancer|April 14, 2005
Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screeningN W J Bulkmans, L Rozendaal, F J Voorhorst, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 5, 2010
Validation of high-risk HPV tests for primary cervical screeningC J L M Meijer, H Berkhof, D A M Heideman, et al.
British Journal of Cancer|January 10, 2008
Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screeningV M H Coupé, J Berkhof, N W J Bulkmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2014
Cervical cancer screening: on the way to a shift from cytology to full molecular screeningM G Dijkstra, P J F Snijders, M Arbyn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006
Human papillomavirus and cervical cancer from a prospective study in Khon Kaen, Northeast ThailandS Sriamporn, P J F Snijders, C Pientong, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 5, 2015
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?M Arbyn, P J F Snijders, C J L M Meijer, et al.
Journal of Clinical Pathology|October 29, 2002
Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomasI Cruz, P J F Snijders, V Van Houten, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|August 23, 2015
Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trialsF Verdoodt, M Jentschke, P Hillemanns, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 14, 2008
[Flat penile lesions in the sexual transmission of human papillomavirus]M C G Bleeker, P J F Snijders, F J Voorhorst, et al.
Preventive Medicine|December 31, 2018
HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programmeN J Polman, P J F Snijders, G G Kenter, et al.
British Journal of Cancer|April 14, 2005
Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screeningN W J Bulkmans, L Rozendaal, F J Voorhorst, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 5, 2010
Validation of high-risk HPV tests for primary cervical screeningC J L M Meijer, H Berkhof, D A M Heideman, et al.
British Journal of Cancer|January 10, 2008
Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screeningV M H Coupé, J Berkhof, N W J Bulkmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2014
Cervical cancer screening: on the way to a shift from cytology to full molecular screeningM G Dijkstra, P J F Snijders, M Arbyn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006
Human papillomavirus and cervical cancer from a prospective study in Khon Kaen, Northeast ThailandS Sriamporn, P J F Snijders, C Pientong, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 5, 2015
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?M Arbyn, P J F Snijders, C J L M Meijer, et al.
Journal of Clinical Pathology|October 29, 2002
Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomasI Cruz, P J F Snijders, V Van Houten, et al.
Pageof 8